Skip to main content
Have a personal or library account? Click to login
Susceptibility of Diabetic Heart to Catecholamine-induced Arrhythmias is Independent of Contractile Dysfunction Cover

Susceptibility of Diabetic Heart to Catecholamine-induced Arrhythmias is Independent of Contractile Dysfunction

EABR. Experimental and Applied Biomedical Research
Volume 15 (2014): Issue 2 (June 2014)
By: ,  ,  ,   and    
Open Access
|Jun 2014
References

References

  1. 1. Dhalla NS, Adameova A, Kaur M. Role of catecholamine oxidation in sudden cardiac death. Fund Clin Pharmacol 2010; 24: 539-46.
    Open DOISearch in Google Scholar
  2. 2. Sethi R, Rehsia NS, Jindal K, et al. Antiarrhythmic effects of some antioxidant vitamins in rats injected with epinephrine. Cardiovasc Toxicol 2009 9: 177-84.
    Open DOISearch in Google Scholar
  3. 3. Sethi R, Adameova A, Dhalla KS, et al. Modification of epinephrine-induced arrhythmias by N-acetyl-Lcysteine and vitamin E. J Cardiovasc Pharmacol Ther 2009; 14:134-42.
    Open DOISearch in Google Scholar
  4. 4. Adameova A, Abdellatif Y, Dhalla NS. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. Can J Physiol Pharmacol 2009; 8: 493-514.
    Open DOISearch in Google Scholar
  5. 5. Goyal BR, Mesariya P, Goyal RK, Mehta AA. Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats. Mol Cell Biochem 2008: 314: 123-31.
    Open DOISearch in Google Scholar
  6. 6. Malone MA, Schocken DD, Hanna SK, Liang X, Malone JI. Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine. Metabolism 2007; 56: 1118-23.
    Open DOISearch in Google Scholar
  7. 7. Nobe S, Aomine M, Arita M, Ito S, Takaki R. Chronic diabetes mellitus prolongs action potential duration of rat ventricular muscles: circumstantial evidence for impaired Ca2+ channel. Cardiovasc Res 1990; 24: 381-9.
    Open DOISearch in Google Scholar
  8. 8. Casis O, Gallego M, Iriarte M, Sanchez-Chapula A. Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle. Diabetologia 2000; 43: 101-9.
    Open DOISearch in Google Scholar
  9. 9. Shimoni Y, Chen K, Emmett T, Kargacin G. Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart. Br J Pharmacol 2008; 154: 675-87.
    Open DOISearch in Google Scholar
  10. 10. Jourdon P, Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol 1993; 470: 411-29.
    Open DOISearch in Google Scholar
  11. 11. Fein FS. Diabetic cardiomyopathy. Diabetes Care 1990; 13: 1169-79.
    Open DOISearch in Google Scholar
  12. 12. Regan TJ, Ahmed S, Haidar B, Moschos C, Weisse A.Diabetic cardiomyopathy: Experimental and clinical observations. New Engl J Med 1994; 91: 776-8.
    Search in Google Scholar
  13. 13. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983; 244: E528-35.
    Open DOISearch in Google Scholar
  14. 14. Rees SA, Curtis MJ. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Circulation 1993; 87: 1979- 1789.
    Open DOISearch in Google Scholar
  15. 15. Barta J, Sanganalmath SK, Kumamoto H, Takeda N, Edes I, Dhalla NS. Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality. Cardiovasc Toxicol 2008; 8: 127-35.
    Open DOISearch in Google Scholar
  16. 16. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction and reperfusion. Cardiovasc Res 1988; 22: 447-55.
    Open DOISearch in Google Scholar
  17. 17. Sanganalmath SK, Babick AP, Barta J, Kumamoto H, Takeda N, Dhalla NS. Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure. J Cell Mol Med 2008; 12: 1728-38.
    Open DOISearch in Google Scholar
  18. 18. Vasanji Z, Dhalla NS, Netticadan T. Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart. Mol Cell Biochem 2004; 261: 245-9.
    Open DOISearch in Google Scholar
  19. 19. Machackova J, Liu X, Lukas A, Dhalla NS. Reninangiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes. Mol Cell Biochem 2004; 261: 271-8.
    Open DOISearch in Google Scholar
  20. 20. Tappia PS, Asemu G, Aroutiounova N, Dhalla NS.Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy. Mol Cell Biochem 2004; 261: 193-9.
    Open DOISearch in Google Scholar
  21. 21. Sauviat MP, Feuvray D. Electrophysiological analysis of the sensitivity to calcium in ventricular muscle from alloxan diabetic rats. Basic Res Cardiol 1986; 81: 489-96.
    Open DOISearch in Google Scholar
  22. 22. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. Long-term effects of streptozotocin- induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Physiology 2005; 90: 827-35.
    Search in Google Scholar
  23. 23. Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD. Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 2002; 90: 483-7.
    Open DOISearch in Google Scholar
  24. 24. Takebayashi K, Sugita R, Tayama K, Aso Y, Takemura Y, Inukai T. The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes.Exp Clin Endocrinol Diabetes 2003; 111: 351-7.
    Open DOISearch in Google Scholar
  25. 25. Dhalla NS, Liu X, Panagia V, Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes.Cardiovasc Res 1998; 40: 239-47.
    Open DOISearch in Google Scholar
  26. 26. Dhalla NS, Takeda N, Rodriquez-Leyva D, Elimban V.Mechanisms of subcellular remodeling in heart failure due to diabetes. Heart Fail Rev 2014; 19: 87-99.
    Open DOISearch in Google Scholar
  27. 27. Marfella R, Rossi F, Giugliano D. Hyperglycemia and QT interval: time for re-evaluation. Diabetes Nutr Metab 2011; 14: 63-5.
    Search in Google Scholar
  28. 28. Christensen NJ. Plasma catecholamines in long-term diabetics with and without neuropathy and in hypophysectomized subjects. J Clin Invest 1972; 51: 779-87.
    Open DOISearch in Google Scholar
  29. 29. Porojan M, Costin M, Poantă L, et al. Autonomic neuropathy and plasma catecholamine in patients with diabetes mellitus. Rom J Intern Med 2010; 48: 341-5.
    Search in Google Scholar
  30. 30. Heyman E, Delamarche P, Berthon P, et al. Alteration in sympathoadrenergic activity at rest and during intense exercise despite normal aerobic fitness in late pubertal adolescent girls with type 1 diabetes. Diabetes Metab 2007; 33: 422-9.
    Open DOISearch in Google Scholar
  31. 31. Kondo K, Matsubara T, Nakamura J, Hotta N. Characteristic patterns of circadian variation in plasma catecholamine levels, blood pressure and heart rate variability in Type 2 diabetic patients. Diabet Med 2002; 19: 359-65.
    Open DOISearch in Google Scholar
  32. 32. Tosaki A, Engelman DT, Engelman RM, Das DK. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts.Cardiovasc Res 1996; 31: 526-36.
    Open DOISearch in Google Scholar
  33. 33. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased.Cardiovasc Res 1997; 34: 113-20.
    Open DOISearch in Google Scholar
  34. 34. Adameova A, Kuzelova M, Andelova E, et al. Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury. Mol Cell Biochem 2007; 295: 129-36.
    Open DOISearch in Google Scholar
  35. 35. Ravingerova T, Adameova A, Matejikova J, et al.. Subcellular mechanisms of adaptation in the diabetic myocardium: Relevance to ischemic preconditioning in the nondiseased heart. Exp Clin Cardiol 2010; 15: 68-76.
    Search in Google Scholar
  36. 36. Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013; 502: 372-6.
    Open DOISearch in Google Scholar
  37. 37. Netticadan T, Temsah RM, Kent A, Elimban V, Dhalla NS. Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 2001; 50: 2133-8.
    Open DOISearch in Google Scholar
  38. 38. Vasanji Z, Cantor EJ, Juric D, Moyen M, Netticadan T. Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. Am J Physiol Cell Physiol 2006; 291: C772-80.
    Open DOISearch in Google Scholar
  39. 39. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 2011; 51:468-73.
    Open DOISearch in Google Scholar
  40. 40. Netticadan T, Temsah RM, Kawabata K, Dhalla NS.Sarcoplasmic reticulum Ca2+/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res 2000; 86: 596-605
    Open DOISearch in Google Scholar
  41. 41. Bhagat BD, Rao PS, Dhalla NS. Role of catecholamines in the genesis of arrhythmias. Adv Myocardial 1980; 2: 117-32.
    Search in Google Scholar
  42. 42. Xu YJ, Tappia PS, Neki NS, Dhalla NS. Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. Heart Fail Rev 2014; 19:113-21.
    Open DOISearch in Google Scholar
  43. 43. Dincer UD, Bidasee KR, Guner S, Tay A, Ozcelikay T, Altan MV. The effect of diabetes on expression of β1-, β2-, and β3-adrenoreceptors in rats hearts. Diabetes 2001; 50: 455-61.
    Open DOISearch in Google Scholar
  44. 44. Op den Buijs J, Miklos Z, Van Riel NAW, et al. β-adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes. Life Sci 2005; 76: 1083-98.
    Open DOISearch in Google Scholar
  45. 45. Woodcock EA, Arthur JF, Matkovich SJ. Inositiol 1,4,5- trisphosphate and reperfusion arrhythmias. Clin Exp Pharmacol Physiol 2000; 27:734-7.
    Open DOISearch in Google Scholar
  46. 46. Tanaka Y, Kashiwagi A, Saeki Y, Shigeta Y. Abnormalities in cardiac α1-adrenoceptor and its signal transduction in streptozotocin-induced diabetic rats. Am J Physiol 1992; 263: E425-9.
    Open DOISearch in Google Scholar
  47. 47. Tanaka Y, Kashiwagi A, Saeki Y, et al. Effects of verapamil on the cardiac α1-adrenoceptor signaling system in diabetic rats. Eur J Pharmacol 1993; 244: 105-9.
    Open DOISearch in Google Scholar
  48. 48. Ziegelhoffer A, Bundgaard H, Ravingerova, et al. Diabetes - and semi-starvation-induced changes in metabolism and regulation of Na, K-ATPase in rat heart.Diabetes Nutr Metab 2003; 16: 222-31.
    Search in Google Scholar
DOI: https://doi.org/10.2478/sjecr-2014-0009 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English, Croatian
Page range: 71 - 78
Submitted on: Mar 12, 2014
Accepted on: May 20, 2014
Published on: Jun 21, 2014
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
diabetes,
arrhythmias,
cardiac dysfunction,
norepinephrine,
epinephrine
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2014 Adriana Adameova, Vijayan Elimban, Delfin Rodriguez-Leyva, Paramjit S. Tappia, Naranjan S Dhalla, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 15 (2014): Issue 2 (June 2014)
Previous article
Next article